Polypharmacy is problematic in patients with fibromyalgia. The purpose of this project was to increase the number of medical cannabis referrals in a rheumatology clinic for patients with fibromyalgia. By implementing an educational intervention on the benefits of medical cannabis for fibromyalgia, the number of medical cannabis referrals increased. The project's results yielded an increase of 4% to 17% in medical cannabis referrals. This was significant, with a Z-score of 2.3143 and a p-value of .0103. The project concluded that the educational intervention on the benefits of medical cannabis for fibromyalgia increased the number of medical cannabis referrals post-intervention compared to pre-intervention. Future research is needed on other integrative therapies for fibromyalgia to reduce polypharmacy. This work is critical for nurses as we continue to advocate for holistic nursing care of our patients.
AdamsN.McVeighJ. G.Cuesta-VargasA.AbokdeerS. (2023). Evidence-based approaches for the management of fibromyalgia syndrome: A scoping review. Physical Therapy Reviews, 28(1), Article 1. https://doi.org/10.1080/10833196.2022.2157945
2.
AdamsonS. J.Kay-LambkinF. J.BakerA. L.LewinT. J.ThorntonL.KellyB. J.DouglasS. (2010). An improved brief measure of cannabis misuse: The Cannabis Use Disorders Identification Test-Revised (CUDIT-R). Drug and Alcohol Dependence, 110(1–2), 137–143. ISSN 0376-8716, https://doi.org/10.1016/j.drugalcdep.2010.02.017
3.
AizuddinA. N.ZamzuriM.‘AmmarI. A.MansorJ.NurumalS. R.YunusS. Z. S. A.RazakM. A. A.JamhariM. N.FahT. S.MiskamH. M.HodR.YusoffH. M. (2022). Perception of integrating complementary and alternative medicine practice in patient’s treatment among the healthcare practitioners: A systematic review. The Pan African Medical Journal, 43, Article 19. https://doi.org/10.11604/pamj.2022.43.19.31133
4.
Americans for Safe Access [ASA]. (2016). A patient’s guide to medical cannabis. Americans for Safe Access. https://american-safeaccesss3.amazonaws.com/patientsguide2017/Patients_guide_11-16_FINAL.pdf
5.
AngS. P.SidharthanS.LaiW.HussainN.PatelK. V.GulatiA.HenryO.KayeA. D.OrhurhuV. (2023). Cannabinoids as a potential alternative to opioids in the management of various pain subtypes: Benefits, limitations, and risks. Pain and Therapy, 12(2), 355–375. https://doi.org/10.1007/s40122-022-00465-y
6.
ArakelyanS.LoneN.AnandA.Mikula-NobleN.LyallM. J.De FerrariL.MercerS. W.GuthrieB. (2023). Effectiveness of holistic assessment-based interventions in improving outcomes in adults with multiple long-term conditions and/or frailty: An umbrella review protocol. JBI Evidence Synthesis, 21(9), 1863–1878. https://doi.org/10.11124/JBIES-22-00406
7.
BenedictG.SabbaghA.ConermannT. (2022). Medical Cannabis used as an alternative treatment for chronic pain demonstrates reduction in chronic opioid use—A prospective study. Pain Physician, 25(1), E113–E119. PMID: 35051158.
8.
BoehnkeK. F.MartelM. O.SmithT.HeY.BergmansR. S.KrugerD. J.AndweleM.BevanS.WilliamsD. A.FitzcharlesM.-A. (2023). Medicinal cannabis use for rheumatic conditions in the US versus Canada: Rationale for use and patient-health care provider interactions. ACR Open Rheumatology, 5(9), 443–453. https://doi.org/10.1002/acr2.11592
9.
BoehnkeK. F.ScottJ. R.LitinasE.SisleyS.WilliamsD. A.ClauwD. J. (2020). High-frequency medical Cannabis use is associated with worse pain among individuals with chronic pain. The Journal of Pain, 21(5–6), 570–581. https://doi.org/10.1016/j.jpain.2019.09.006
10.
BravoC.Rubí-CarnaceaF.ColomoI.Sánchez-de-la-TorreM.Fernández-LagoH.Climent-SanzC. (2024). Aquatic therapy improves self-reported sleep quality in fibromyalgia patients: A systematic review and meta-analysis. Sleep & Breathing = Schlaf & Atmung, 28(2), 565–583. https://doi.org/10.1007/s11325-023-02933-x
11.
BruceD.BradyJ. P.FosterE.ShattellM. (2018). Preferences for medical marijuana over prescription medications among persons living with chronic conditions: Alternative, complementary, and tapering uses. Journal of Alternative and Complementary Medicine (New York, N.Y.), 24(2), 146–153. https://doi.org/10.1089/acm.2017.0184
12.
BuonomanoL. S.MitnickM. M.McCalmontT. R.SyracuseP.DugoshK. L.FestingerD. S.LentM. R. (2022). Clinical characteristics and quality of life in adults initiating medical marijuana treatment. Medical Cannabis and Cannabinoids, 5(1), 95–101. https://doi.org/10.1159/000524831
Centers for Disease Control and Prevention [CDC]. (2024). Fibromyalgia. Centers for Disease Control and Prevention. https://www.cdc.gov/arthritis/basics/fibromyalgia.htm
15.
ChinnP. L.KramerM. K. (2013). Integrated Theory & Knowledge Development in Nursing (eBook: Vol. 8th Ed.). Mosby.
16.
ClobesT. A.PalmierL. A.GagnonM.KlaimanC.ArellanoM. (2022). The impact of education on attitudes toward medical cannabis. PEC Innovation, 1, 100009. https://doi.org/10.1016/j.pecinn.2021.100009
17.
CorroonJ. M.MischleyL. K.SextonM. (2017). Cannabis as a substitute for prescription drugs—A cross-sectional study. Journal of Pain Research, 10, 989–998. https://doi.org/10.2147/JPR.S134330
18.
DahlhamerJ.LucasJ.ZelayaC.NahinR.MackeyS.DeBarL.KernsR.Von KorffM.PorterL.HelmickC. (2018). Prevalence of chronic pain and high-impact chronic pain among adults—United States, 2016. MMWR. Morbidity and Mortality Weekly Report, 67(36), 1001–1006. https://doi.org/10.15585/mmwr.mm6736a2
19.
FillonM. (2023). Clinicians need to stay current with polypharmacy concerns. CA: A Cancer Journal for Clinicians, 73(4), 341–343. https://doi.org/10.3322/caac.21803
20.
GoodP.HaywoodA.GognaG.MartinJ.YatesP.GreerR.HardyJ. (2019). Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: A double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD). BMC Palliative Care, 18(1), 110. https://doi.org/10.1186/s12904-019-0494-6
21.
HabibG.ArtulS. (2018). Medical cannabis for the treatment of fibromyalgia. Journal of Clinical Rheumatology: Practical Reports on Rheumatic & Musculoskeletal Diseases, 24(5), 255–258. https://doi.org/10.1097/RHU.0000000000000702
22.
HabibG.KhazinF.ArtulS. (2021). The effect of medical cannabis on pain level and quality of sleep among rheumatology clinic outpatients. Pain Research & Management, 2021, 1756588. https://doi.org/10.1155/2021/1756588
23.
HabibG.LevingerU. (2020). Characteristics of medical cannabis usage among patients with fibromyalgia. Harefuah, 159(5), 343–348.
24.
HjorthøjC.La CourP.NordentoftM.PosseltC. M. (2022). Cannabis-based medicines and medical cannabis for patients with neuropathic pain and other pain disorders: Nationwide register-based pharmacoepidemiologic comparison with propensity score matched controls. European Journal of Pain (London, England), 26(2), 480–491. https://doi.org/10.1002/ejp.1874
HussainS. T.LeiS.AkramT.HaiderM. J.HussainS. H.AliM. (2018). Kurt Lewin’s change model: A critical review of the role of leadership and employee involvement in organizational change. Journal of Innovation & Knowledge, 3(3), 123–127. https://doi.org/10.1016/j.jik.2016.07.002
27.
JainN.MoorthyA. (2022). Cannabinoids in rheumatology: Friend, foe or a bystander?Musculoskeletal Care, 20(2), 416–428. https://doi.org/10.1002/msc.1636
28.
JakobJ.StalderO.SyrogiannouliL.PletcherM. J.VittinghoffE.NingH.TalK.RanaJ. S.SidneyS.Lloyd-JonesD. M.AuerR. (2021). Association between marijuana use and electrocardiographic abnormalities by middle age: The coronary artery risk development in young adults (CARDIA) study. Addiction (Abingdon, England), 116(3), 583–595. https://doi.org/10.1111/add.15188
KrugerD. J.MokbelM. A.ClauwD. J.BoehnkeK. F. (2022). Assessing health care providers’ knowledge of medical cannabis. Cannabis and Cannabinoid Research, 7(4), 501–507. https://doi.org/10.1089/can.2021.0032
31.
KurlyandchikI.TiralongoE.SchlossJ. (2021). Safety and efficacy of medicinal cannabis in the treatment of fibromyalgia: A systematic review. Journal of Alternative and Complementary Medicine (New York, N.Y.), 27(3), 198–213. https://doi.org/10.1089/acm.2020.0331
LikhitsathianS.EdelsteinO. E.SrisurapanontM.ZolotovY.KarawekpanyawongN.ReznikA.IsralowitzR. (2021). Cross national comparison of medical students’ attitudes and beliefs about medical cannabis and its application for pain management. Complementary Therapies in Medicine, 59, 102720. https://doi.org/10.1016/j.ctim.2021.102720
34.
LucasP.BaronE. P.JikomesN. (2019). Medical cannabis patterns of use and substitution for opioids & other pharmaceutical drugs, alcohol, tobacco, and illicit substances; results from a cross-sectional survey of authorized patients. Harm Reduction Journal, 16(1), 9. https://doi.org/10.1186/s12954-019-0278-6
35.
ManningL.BouchardL. (2021). Medical cannabis use: Exploring the perceptions and experiences of older adults with chronic conditions. Clinical Gerontologist, 44(1), 32–41. https://doi.org/10.1080/07317115.2020.1853299
36.
MazzaM. (2021). Medical cannabis for the treatment of fibromyalgia syndrome: A retrospective, open-label case series. Journal of Cannabis Research, 3(1), 4. https://doi.org/10.1186/s42238-021-00060-6
MeyersS.GantK.BurmeisterM. (2024). Assessment of education in a community hospital on healthcare providers’ knowledge of and attitudes toward medical marijuana. Currents in Pharmacy Teaching and Learning, 16(6), 396–403. https://doi.org/10.1016/j.cptl.2024.03.007
39.
NeumanB. (1974). The Betty Neuman healthcare systems model: A total person approach to patient problems. In RiehlJ. P.RoyC. (Eds.), Conceptual models for nursing practice (pp. 99–114). Appleton-Century-Crofts.
40.
PangH. Y.FarrerC.WuW.GakhalN. K. (2021). Quality of rheumatology care for patients with fibromyalgia and chronic pain syndromes. BMJ Open Quality, 10(1), e001061. https://doi.org/10.1136/bmjoq-2020-001061
41.
PapathanasiouI.SklavouM.KourkoutaL. (2013). Holistic nursing care: Theories and perspectives. American Journal of Nursing Science, 2(1), Article 1. https://doi.org/10.11648/j.ajns.20130201.11
PradosG.MiróE.MartínezM. P.SánchezA. I.LamiM. J.CálizR. (2020). Combined cognitive-behavioral therapy for fibromyalgia: Effects on polysomnographic parameters and perceived sleep quality. International Journal of Clinical and Health Psychology : IJCHP, 20(3), 232–242. https://doi.org/10.1016/j.ijchp.2020.04.002
45.
SafakishR.KoG.SalimpourV.HendinB.SohanpalI.LoheswaranG.YoonS. Y. R. (2020). Medical Cannabis for the management of pain and quality of life in chronic pain patients: A prospective observational study. Pain Medicine (Malden, Mass.), 21(11), 3073–3086. https://doi.org/10.1093/pm/pnaa163
46.
SazegarP. (2021). Cannabis essentials: Tools for clinical practice. American Family Physician, 104(6), 598–608.
UmapathiK. K.ThavamaniA.DhanpalreddyH.NguyenH. H. (2021). Prevalence of cardiac arrhythmias in cannabis use disorder related hospitalizations in teenagers from 2003 to 2016 in the United States. Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology, 23(8), 1302–1309. https://doi.org/10.1093/europace/euab033
50.
WalittB.NahinR. L.KatzR. S.BergmanM. J.WolfeF. (2015). The prevalence and characteristics of fibromyalgia in the 2012 national health interview survey. PloS One, 10(9), e0138024. https://doi.org/10.1371/journal.pone.0138024
51.
WangC.ErridgeS.HolveyC.CoomberR.UsmaniA.SajadM.GuruR.HoldenW.RuckerJ. J.PlattM. W.SodergrenM. H. (2023). Assessment of clinical outcomes in patients with fibromyalgia: Analysis from the UK medical cannabis registry. Brain and Behavior, 13(7), e3072. https://doi.org/10.1002/brb3.3072
52.
WorsterB.AshareR. L.HajjarE.GarberG.SmithK.KellyE. L. (2023). Clinician attitudes, training, and beliefs about cannabis: An interprofessional assessment. Cannabis and Cannabinoid Research, 8(3), 547–556. https://doi.org/10.1089/can.2021.0022
